West Virginia · 2026 Regular Session · Bill
HB 4075: Insurance must cover Bioidentical hormones as they do pharmaceutical one
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 4075 is a bill introduced in the West Virginia House on January 14, 2026. According to its official title, it concerns: Insurance must cover Bioidentical hormones as they do pharmaceutical one. Primary sponsor: Kathie Hess Crouse (Republican). It lists 2 additional sponsors. Most recent recorded action (January 14, 2026): To House Finance.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kathie Hess Crouse | Primary sponsor | Republican | House | 19 |
| Tresa Howell | Co-sponsor | Republican | House | 52 |
| Lisa White | Co-sponsor | Republican | House | 96 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- To House Finance
- Introduced in House
- To Finance then Judiciary
- Filed for introduction